An observational study in Central Lung Cancer, sponsored by The Central Hospital of Lishui City. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-14.
Sponsored by The Central Hospital of Lishui City · Observational
This study is a retrospective, multicenter clinical study. The main goal is to identify the risk factors for cavity formation in central-type lung cancer lesions, and to construct a prediction model for cavity formation in central-type lung cancer lesions based on the above risk factors.
The Central Hospital of Lishui City is the lead sponsor of 10 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
This is a multicenter study. Patients from Lishui Central Hospital of Zhejiang Province, the Second Affiliated Hospital of Medical College of Zhejiang University, and Affiliated Hospital of Xinjiang Medical University who meet the above criteria will be included in this study
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Formation of cavities in the central lung cancer, assessed up to 18 months.
Time from enrollment to the time of cavities formation, assessed up to 18 months.
Time frame: Time from enrollment to the time of cavities formation, assessed up to 18 months.
Hemoptysis in patients with central lung cancer, assessed up to 18 months.
Time from enrollment to hemoptysis, assessed up to 18 months.
Time frame: Time from enrollment to hemoptysis, assessed up to 18 months.
No study locations are listed for this record.
Plan to share: Yes — Statistical analysis plan, informed consent form, and clinical study report can be shared with other researchers.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: Within six months after the trial is completed.
Access criteria: Shared data is not available for downloading, but can only be browsed. To download the data, you must contact the researchers. Shared data does not provide any private information of the participants.
No publications or documents are linked to this record.
Start is estimated for Mar 2022; primary completion for May 2022, 2 months later.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Central Hospital of Lishui City